Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

Transcriptomic comparison on the mechanism of action of four major constituent cannabinoids in hemp extract.

Journal of cannabis research·2026
Same author

An Accurate Method Based on Ultra-High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry for the Quantification of Five Cannabinoids in Juvenile and Adult Caenorhabditis elegans.

Journal of separation science·2026
Same author

Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing.

ACS omega·2026
Same author

Library docking for Cannabinoid-2 Receptor ligands.

bioRxiv : the preprint server for biology·2026
Same author

Drug-induced phospholipidosis as an artifact in antiviral drug repurposing.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jun 7, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.5K

In Vitro Biological Target Screening and Colloidal Aggregation of Minor Cannabinoids.

Michael F Santillo1, Isabella S Glenn2, Lu Paris2

  • 1Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, United States Food and Drug Administration (FDA), Laurel, Maryland 20708, United States.

Journal of Natural Products
|November 20, 2024
PubMed
Summary

Seven cannabinoids were screened against 44 safety targets. Colloidal aggregates were detected, potentially causing false positive results in drug interaction studies.

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.3K

Related Experiment Videos

Last Updated: Jun 7, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.5K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.3K

Area of Science:

  • Pharmacology
  • Toxicology
  • Biochemistry

Background:

  • Limited data exists on interactions between cannabinoids and human biological targets.
  • Understanding these interactions is crucial for assessing cannabinoid safety and efficacy.
  • Pharmacologically relevant targets include receptors, ion channels, enzymes, and transporters.

Purpose of the Study:

  • To investigate the interactions of seven cannabinoids with 44 safety-related biological targets.
  • To identify potential off-target effects and drug interactions of cannabinoids.
  • To assess the reliability of current screening methods in the presence of cannabinoid aggregates.

Main Methods:

  • Competitive ligand binding assays were used to assess target interactions.
  • Enzymatic activity assays were employed to evaluate functional inhibition.
  • Dynamic light scattering (DLS) was utilized to detect colloidal aggregates.
  • A detergent-sensitive enzyme inhibition assay was performed to further investigate aggregate effects.

Main Results:

  • Diverse binding profiles were observed among the seven screened cannabinoids.
  • Colloidal aggregates were detected in the cannabinoid preparations using DLS.
  • Evidence suggests these aggregates may lead to non-specific inhibition of biological targets.
  • The presence of aggregates raises concerns about potential false positive findings in screening assays.

Conclusions:

  • The study identified potential interactions between cannabinoids and various safety-related targets.
  • The presence of colloidal aggregates is a significant confounding factor in cannabinoid screening.
  • Further investigation is needed to confirm cannabinoid aggregation in specific in vitro assays.
  • Accurate assessment of cannabinoid pharmacology and toxicology requires addressing aggregate formation.